Targeted treatment for severe COPD approved by NICE

South_agency/Getty Images

By Olivia Bowthorpe

People in England with uncontrolled chronic obstructive pulmonary disease (COPD) who still experience flare-ups on inhaler therapy will soon have access to a new targeted treatment.

Around 30,000 patients will be eligible for the biologic drug dupilumab after its approval by the National Institute for Health and Care Excellence (NICE).